Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis-Reference-Cited by-同舟云学术

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

Published:2005-04 Issue:4 Volume:7 Page:387-397
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Levine Ross L.,Wadleigh Martha,Cools Jan,Ebert Benjamin L.,Wernig Gerlinde,Huntly Brian J.P.,Boggon Titus J.,Wlodarska Iwona,Clark Jennifer J.,Moore Sandra,Adelsperger Jennifer,Koo Sumin,Lee Jeffrey C.,Gabriel Stacey,Mercher Thomas,D’Andrea Alan,Fröhling Stefan,Döhner Konstanze,Marynen Peter,Vandenberghe Peter,Mesa Ruben A.,Tefferi Ayalew,Griffin James D.,Eck Michael J.,Sellers William R.,Meyerson Matthew,Golub Todd R.,Lee Stephanie J.,Gilliland D. Gary

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Oncology

Reference50 articles.

1. Polycythemia vera: Stem-cell and probable clonal origin of the disease;Adamson;N. Engl. J. Med.,1976

2. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta;Apperley;N. Engl. J. Med.,2002

3. Familial erythrocytosis associated with a short deletion in the erythropoietin receptor gene;Arcasoy;Blood,1997

4. Translocation of c-ab1 oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia;Bartram;Nature,1983

5. A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome;Cools;N. Engl. J. Med.,2003

Cited by 2554 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloproliferative disorder associated with alopecia universalis;JAAD Case Reports;2024-10

2. SOHO State of the Art Updates and Next Questions | Choosing and Properly Using a JAK Inhibitor in Myelofibrosis;Clinical Lymphoma Myeloma and Leukemia;2024-09

3. Structural basis of MPL activation by thrombopoietin;Blood Vessels, Thrombosis & Hemostasis;2024-09

4. Clonal Hematopoiesis from a Diagnostic Perspective: 10 Years of CHIP;Molecular Diagnosis & Therapy;2024-08-20

5. Microbial and transcriptional response of Acropora valida and Turbinaria peltata to Vibrio coralliilyticus challenge: insights into corals disease resistance;BMC Microbiology;2024-08-02